BC
VIVO

Brinker Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Brinker Capital’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$940K Sell
40,359
-33,899
-46% -$491K 0.03% 514
2020
Q1 		$624K Buy
74,258
+25,449
+52% +$214K 0.02% 567
2019
Q4 		$477K Sell
48,809
-23,093
-32% -$217K 0.01% 725
2019
Q3 		$682K Buy
71,902
+9,653
+16% +$102K 0.02% 609
2019
Q2 		$740K Buy
62,249
+12,810
+26% +$154K 0.03% 580
2019
Q1 		$871K Sell
49,439
-1,434
-3% -$23.9K 0.03% 505
2018
Q4 		$883K Sell
50,873
-3,926
-7% -$67K 0.04% 435
2018
Q3 		$817K Buy
54,799
+2,715
+5% +$42.1K 0.03% 553
2018
Q2 		$828K Buy
52,084
+3,330
+7% +$49.7K 0.03% 542
2018
Q1 		$692K Sell
48,754
-216
-0.4% -$3.2K 0.03% 598
2017
Q4 		$686K Buy
+48,970
New +$717K 0.03% 580

Other funds holding VIVO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return

Brinker Capital's VIVO Position: Q2 2020 in Review

Brinker Capital reduced its Meridian Bioscience Inc (VIVO) stake by 46% in Q2 2020, selling an estimated $491K and leaving 40,359 shares worth $940K. The position accounts for 0.03% of the portfolio, ranked #514.

Brinker Capital first reported a position in VIVO in Q4 2017 and has held it in 11 quarters since. 191 funds tracked by Wall St. Rank hold VIVO as of Q2 2020.

  • Brinker Capital held 40,359 shares of Meridian Bioscience Inc worth $940K as of Q2 2020.
  • Brinker Capital sold 33,899 Meridian Bioscience Inc shares in Q2 2020, an estimated $491K.
  • Meridian Bioscience Inc made up 0.03% of Brinker Capital's portfolio in Q2 2020, its #514 holding.
  • Brinker Capital first reported a position in Meridian Bioscience Inc in Q4 2017 and has held it in 11 quarters since.
  • 191 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2020.

Based on Brinker Capital's 13F filing for Q2 2020, filed 30 Jul 2020.